Following is a cumulative list of Hoosier Cancer Research Network publications in myelodysplastic syndromes.

Manuscripts and Journal Articles

• Sayar H, Chan RJ, Orschell CM, Chan EM, Yu Z, Hood D, Plett A, Yang Z, Hui CL, Nabinger SC, Kohlbacher KJ, West ES, Walter A, Sampson C, Wu J, Cripe LD. Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group MDS04-85. Leuk Res. 2011 Aug;35(8):1108-10. doi: 10.1016/j.leukres.2011.02.025. Epub 2011 Mar 21.
• Vaena DA, Walker P, Pennington K, Stephens A, Stender MJ, Yiannoutsos CT, Young C, Stoner C, Cripe LD. Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study. MDS98-1. Leuk Res. 2004 Jan;28(1):49-52. See abstract.

Abstracts, Posters, and Presentations

• Daniel Vaena, Larry Cripe, Lawrence Einhorn, Paul Walker, Kenneth Pennington, Carol Young, Cindy Stoner. Phase II Study of Low-Dose Topotecan in Myelodysplastic Syndromes: A Hoosier Oncology Group Study MDS98-1. Accepted as a poster presentation for ASCO Annual Meeting May 18-21, 2002, Orlando, FL.